Retraction
Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway
Paper Information
Record ID:
40880
Author(s):
Publication Date:
January 07, 2021
Retraction Date:
November 16, 2022
(3.0 years years ago)
Subjects:
Institutions:
- Department of Radiotherapy, Yantaishan Hospital, Yantai 264000, People’s Republic of China
- Department of Tuberculosis, Shandong Provincial Chest Hospital, Jinan 250013, People’s Republic of China
- Department of Respiratory and Critical Care, Shandong Provincial Chest Hospital, Jinan 250013, People’s Republic of China
- Department of Oncology, Yantai Hospital of Traditional Chinese Medicine, Yantai 264000, People’s Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (10)
10
Total Citations4
Post-Retraction(40.0%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
2
After 2+ years
884
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasis
Li-jun Yang, Jiping Li
Clinical & Experimental Metastasis
Published: Apr 2025
884 days after retraction
Paper citing Liver Kinase B1 (LKB1) Regulates Proliferation and...
Unknown Authors
Unknown Journal
Published: Feb 2025
808 days after retraction
Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
Mu Pang, Xizhe Sun, Tingchao He et al. (6 authors)
Aging
Open Access
Published: Oct 2023
1 citation
1 citation
320 days after retraction
Potential roles of exosomes in the initiation and metastatic progression of lung cancer
Hongyuan Liang, Lingyun Zhang, Jian Rong
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2023
4 citations
4 citations
264 days after retraction
A Anoikis-Related Risk Model: Predicts Prognosis and Immunotherapy Response for Hepatocellular Carcinoma
Haitao Ren, Na Kang, Shuan Yin et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Nov 2022
2 days before retraction
LKB1: Can We Target an Hidden Target? Focus on NSCLC
Gloriana Ndembe, Ilenia Intini, Elisa Perin et al. (9 authors)
Frontiers in Oncology
Open Access
Published: May 2022
19 citations
19 citations
189 days before retraction
Preparation and characterization of 2-deacetyl-3-O-sulfo-heparosan and its antitumor effects via the fibroblast growth factor receptor pathway
Zhengqi Zha, Yaoyao Liu, Yinghua Miao et al. (7 authors)
International Journal of Biological Macromolecules
Published: Jan 2022
4 citations
4 citations
315 days before retraction
RETRACTED: A Novel Tumor Suppressor Gene, ZNF24, Inhibits the Development of NSCLC by Inhibiting the WNT Signaling Pathway to Induce Cell Senescence
Bo Pang, Yong Wang, Xiaoyan Chang
Frontiers in Oncology
Open Access
Published: Jul 2021
4 citations
4 citations
477 days before retraction
Molecular and Cellular Mechanisms of Metformin in Cervical Cancer
Yahui Chen, Po-Hui Wang, Pei‐Ni Chen et al. (5 authors)
Cancers
Open Access
Published: May 2021
30 citations
30 citations
543 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025